{"ModuleTitle": "Company Description", "CompanyName": "United Therapeutics Corporation", "Symbol": "UTHR", "Address": "1040 SPRING ST, SILVER SPRING, Maryland, 20910, United States of America", "Phone": "3016089292", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "United Therapeutics Corporation focuses on the strength of a balanced,\r\nvalue-creating biotechnology model. We are confident in our future thanks to our\r\nfundamental attributes, namely our obsession with quality and innovation, the\r\npower of our brands, our entrepreneurial culture and our bioinformatics\r\nleadership. We also believe that our determination to be responsible citizens --\r\nhaving a positive impact on patients, the environment and society -- will sustain\r\nour success in the long term.\r\n\r\nThrough our wholly-owned subsidiary, Lung Biotechnology PBC, we are focused on\r\naddressing the acute national shortage of transplantable lungs and other organs\r\nwith a variety of technologies that either delay the need for such organs or\r\nexpand the supply. Lung Biotechnology is the first public benefit corporation\r\nsubsidiary of a public biotechnology or pharmaceutical company.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f26%2f0001104659-20-025009.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "James Christopher Edgemond", "title": "CFO, Treasurer & Principal Accounting Officer"}, {"name": "Martine A. Rothblatt", "title": "Chairman & Chief Executive Officer"}, {"name": "Michael Ian Benkowitz", "title": "President & Chief Operating Officer"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}